Matthew S. Parsons

1.9k total citations
61 papers, 1.4k citations indexed

About

Matthew S. Parsons is a scholar working on Immunology, Virology and Infectious Diseases. According to data from OpenAlex, Matthew S. Parsons has authored 61 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Immunology, 43 papers in Virology and 13 papers in Infectious Diseases. Recurrent topics in Matthew S. Parsons's work include Immune Cell Function and Interaction (45 papers), HIV Research and Treatment (43 papers) and T-cell and B-cell Immunology (26 papers). Matthew S. Parsons is often cited by papers focused on Immune Cell Function and Interaction (45 papers), HIV Research and Treatment (43 papers) and T-cell and B-cell Immunology (26 papers). Matthew S. Parsons collaborates with scholars based in Australia, Canada and United States. Matthew S. Parsons's co-authors include Stephen J. Kent, Ivan Stratov, Andrés Finzi, Wen Shi Lee, Jonathan Richard, Leia Wren, Amy W. Chung, Gamze Isitman, Nicole F. Bernard and Bruce D. Wines and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and PLoS ONE.

In The Last Decade

Matthew S. Parsons

60 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew S. Parsons Australia 25 1.1k 878 341 315 290 61 1.4k
Zelda Euler Netherlands 15 615 0.6× 956 1.1× 297 0.9× 170 0.5× 376 1.3× 23 1.2k
Barbara Volsky United States 17 661 0.6× 1.0k 1.2× 311 0.9× 215 0.7× 417 1.4× 25 1.3k
Amarendra Pegu United States 18 678 0.6× 857 1.0× 289 0.8× 390 1.2× 518 1.8× 31 1.4k
Jovana Golijanin United States 11 667 0.6× 767 0.9× 319 0.9× 182 0.6× 370 1.3× 11 1.3k
Ariel Halper-Stromberg United States 8 626 0.6× 889 1.0× 338 1.0× 190 0.6× 360 1.2× 8 1.1k
John Pietzsch United States 8 681 0.6× 694 0.8× 434 1.3× 164 0.5× 207 0.7× 8 1.1k
Kwinten Sliepen Netherlands 17 632 0.6× 778 0.9× 384 1.1× 240 0.8× 310 1.1× 33 1.3k
Christopher Sundling Sweden 20 984 0.9× 453 0.5× 168 0.5× 201 0.6× 233 0.8× 52 1.4k
Jonathan Richard Canada 30 1.2k 1.1× 1.5k 1.7× 308 0.9× 360 1.1× 932 3.2× 85 2.3k
Jérémie Prévost Canada 22 522 0.5× 684 0.8× 190 0.6× 193 0.6× 660 2.3× 57 1.2k

Countries citing papers authored by Matthew S. Parsons

Since Specialization
Citations

This map shows the geographic impact of Matthew S. Parsons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew S. Parsons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew S. Parsons more than expected).

Fields of papers citing papers by Matthew S. Parsons

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew S. Parsons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew S. Parsons. The network helps show where Matthew S. Parsons may publish in the future.

Co-authorship network of co-authors of Matthew S. Parsons

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew S. Parsons. A scholar is included among the top collaborators of Matthew S. Parsons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew S. Parsons. Matthew S. Parsons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Parsons, Matthew S. & Diane L. Bolton. (2025). The utility of nonhuman primate models for understanding acute HIV-1 infection. Current Opinion in HIV and AIDS. 20(3). 218–227. 1 indexed citations
2.
Lee, Wen Shi, Arnold Reynaldi, Thakshila Amarasena, et al.. (2021). Anti-Drug Antibodies in Pigtailed Macaques Receiving HIV Broadly Neutralising Antibody PGT121. Frontiers in Immunology. 12. 749891–749891. 5 indexed citations
3.
Selva, Kevin J., Jennifer A. Juno, Amy W. Chung, et al.. (2019). Short Communication: Effect of Seminal Plasma on Functions of Monocytes and Granulocytes. AIDS Research and Human Retroviruses. 35(6). 553–556. 2 indexed citations
4.
Parsons, Matthew S., Wen Shi Lee, Anne B. Kristensen, et al.. (2018). Fc-dependent functions are redundant to efficacy of anti-HIV antibody PGT121 in macaques. Journal of Clinical Investigation. 129(1). 182–191. 67 indexed citations
5.
Alsahafi, Nirmin, Jonathan Richard, Jérémie Prévost, et al.. (2017). Impaired Downregulation of NKG2D Ligands by Nef Proteins from Elite Controllers Sensitizes HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity. Journal of Virology. 91(16). 27 indexed citations
6.
Lewis, George K., Marzena Pazgier, David T. Evans, et al.. (2017). Beyond Viral Neutralization. AIDS Research and Human Retroviruses. 33(8). 760–764. 31 indexed citations
7.
Vanderven, Hillary A., Lu Liu, Fernanda Ana‐Sosa‐Batiz, et al.. (2017). Fc functional antibodies in humans with severe H7N9 and seasonal influenza. JCI Insight. 2(13). 40 indexed citations
8.
Parsons, Matthew S., Wen Shi Lee, Anne B. Kristensen, et al.. (2017). Partial efficacy of a broadly neutralizing antibody against cell-associated SHIV infection. Science Translational Medicine. 9(402). 45 indexed citations
9.
Parsons, Matthew S., Jonathan Richard, Wen Shi Lee, et al.. (2016). NKG2D Acts as a Co-Receptor for Natural Killer Cell-Mediated Anti-HIV-1 Antibody-Dependent Cellular Cytotoxicity. AIDS Research and Human Retroviruses. 32(10-11). 1089–1096. 30 indexed citations
10.
Selva, Kevin J., Stephen J. Kent, & Matthew S. Parsons. (2016). Modulation of innate and adaptive cellular immunity relevant to HIV-1 vaccine design by seminal plasma. AIDS. 31(3). 333–342. 11 indexed citations
11.
Veillette, Maxime, Jonathan Richard, Marzena Pazgier, et al.. (2015). Role of HIV-1 Envelope Glycoproteins Conformation and Accessory Proteins on ADCC Responses. Current HIV Research. 14(1). 9–23. 37 indexed citations
12.
Lee, Wen Shi, et al.. (2015). Can HIV-1-Specific ADCC Assist the Clearance of Reactivated Latently Infected Cells?. Frontiers in Immunology. 6. 265–265. 25 indexed citations
13.
14.
Winnall, Wendy R., Matthew D. Beasley, Matthew S. Parsons, Ben R. Kiefel, & Stephen J. Kent. (2014). The maturation of antibody technology for the HIV epidemic. Immunology and Cell Biology. 92(7). 570–577. 5 indexed citations
15.
Wren, Leia, Wendy R. Winnall, Matthew S. Parsons, et al.. (2014). Breadth of HIV-1 Env-specific antibody-dependent cellular cytotoxicity. AIDS. 28(13). 1859–1870. 35 indexed citations
16.
Richard, Jonathan, et al.. (2014). Slaying the Trojan Horse: Natural Killer Cells Exhibit Robust Anti-HIV-1 Antibody-Dependent Activation and Cytolysis against Allogeneic T Cells. Journal of Virology. 89(1). 97–109. 42 indexed citations
17.
Parsons, Matthew S., Jean‐Pierre Routy, Danielle Rouleau, et al.. (2013). Antibody Responses to Human Immunodeficiency Virus Envelope from Infections with Multiple Subtypes Utilize the 1F7-Idiotypic Repertoire. AIDS Research and Human Retroviruses. 29(5). 1 indexed citations
18.
Parsons, Matthew S., et al.. (2013). Anti-HIV Antibody–Dependent Activation of NK Cells Impairs NKp46 Expression. The Journal of Immunology. 192(1). 308–315. 30 indexed citations
19.
Wren, Leia, Matthew S. Parsons, Gamze Isitman, et al.. (2012). Influence of Cytokines on HIV-Specific Antibody-Dependent Cellular Cytotoxicity Activation Profile of Natural Killer Cells. PLoS ONE. 7(6). e38580–e38580. 19 indexed citations
20.
Parsons, Matthew S., et al.. (2010). Distinct Phenotype of Unrestricted Cytotoxic T lymphocytes from Human Immunodeficiency Virus-infected Individuals. Journal of Clinical Immunology. 30(2). 272–279. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zelda Euler Breakdown of academic impact, for papers by Barbara Volsky Breakdown of academic impact, for papers by Amarendra Pegu Breakdown of academic impact, for papers by Jovana Golijanin Breakdown of academic impact, for papers by Ariel Halper-Stromberg Breakdown of academic impact, for papers by John Pietzsch Breakdown of academic impact, for papers by Kwinten Sliepen Breakdown of academic impact, for papers by Christopher Sundling Breakdown of academic impact, for papers by Jonathan Richard Breakdown of academic impact, for papers by Jérémie Prévost
Rankless by CCL
2026